Brind.

Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.

5 reports, 5 independent Updated Fri 00:00

No new developments lately Reached 2 outlets in its first 24 hours

Reports: 5
Developments: 2
Repetition: 60%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 5 independent outlets

Carlos Santos was appointed CFO of Legend Biotech, with financial expertise provided by AstraZeneca, Novartis, and Intel.

Who's involved

What this event is mainly about

Legend Biotech Carlos Santos

How it developed

Newest first. Tap a step to see who reported it.

Jul 27Legend Biotech appoints Alan Bash as Interim CEO.1 source
- manilatimes.net
Aug 30Legend Biotech appoints Carlos Santos as CFO, leveraging expertise from AstraZeneca, Novartis, and Intel.1 source
- Simply Wall St.

Keep exploring

The entities involved

Legend Biotech
Biotech company

Nothing else this week.
Carlos Santos
Portuguese visual artist (1975-)

Nothing else this week.

Coverage

Newest first; wire copies grouped

Fri 00:00insidermonkey.com
Jul 29yahoo.com
Jul 27manilatimes.netLegend Biotech Announces CEO Transition
Aug 30Simply Wall St.The Bull Case For Legend Biotech (LEGN) Could Change Following Appointment of CFO With Global Pharma Expertise On August 18, 2025, Legend Biotech appointed Carlos Santos as Chief Financial Officer an
Aug 18GlobeNewswireLegend Biotech Appoints Carlos Santos as Chief Financial Officer SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell